Trials / Completed
CompletedNCT00230776
A Controlled Pregabalin Trial In Fibromyalgia
A 14-Week, Randomized, Double-Blind, Placebo-Controlled Trial Of Pregabalin Twice Daily In Patients With Fibromyalgia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 740 (planned)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy and safety of pregabalin compared with placebo for the relief of pain associated with fibromyalgia and improvement of function of patients with fibromyalgia
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pregabalin | |
| DRUG | placebo |
Timeline
- Start date
- 2005-10-01
- Completion
- 2006-07-01
- First posted
- 2005-10-03
- Last updated
- 2021-01-26
Locations
89 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00230776. Inclusion in this directory is not an endorsement.